Moxetumomab pasudotox-tdfk Intravenous and Sinemet CR 100/25
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Sinemet CR 100/25 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Sinemet CR 200/50
- Moxetumomab pasudotox-tdfk Intravenous-Sinequan
- Moxetumomab pasudotox-tdfk Intravenous-Sinequan (Doxepin Capsules)
- Moxetumomab pasudotox-tdfk Intravenous-Sinequan (Doxepin Oral Concentrate)
- Moxetumomab pasudotox-tdfk Intravenous-Sinex Long-Acting
- Moxetumomab pasudotox-tdfk Intravenous-Sinex Nasal Spray
- Sinemet CR 100/25-Moxifloxacin
- Sinemet CR 100/25-Moxifloxacin (Systemic)
- Sinemet CR 100/25-Moxifloxacin Hydrochloride
- Sinemet CR 100/25-Moxifloxacin Injection
- Sinemet CR 100/25-Moxifloxacin Intravenous
- Sinemet CR 100/25-Moxifloxacin Tablets